These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2354287)

  • 1. Risk behaviour and HTLV-1 seropositivity in injecting drug users.
    Rezza G; Lazzarin A; Uberti-Foppa C; Tumbarello M; Menniti-Ippolito F; Pezzotti P; Titti F; Verani P
    Br J Addict; 1990 May; 85(5):686-7. PubMed ID: 2354287
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors for human T cell lymphotropic virus type I among injecting drug users in northeast Brazil: possibly greater efficiency of male to female transmission.
    Dourado I; Andrade T; Carpenter CL; Galvão-Castro B
    Mem Inst Oswaldo Cruz; 1999; 94(1):13-8. PubMed ID: 10029907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HTLV-I/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users.
    Page JB; Lai SH; Chitwood DD; Klimas NG; Smith PC; Fletcher MA
    Lancet; 1990 Jun; 335(8703):1439-41. PubMed ID: 1972217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of HTLV-I and HTLV-II infection in prostitutes in the area of Seville, Spain.
    Calderón EJ; Gómez-Lucia E; Aguado I; Pineda JA; Essex M; Leal M
    Eur J Clin Microbiol Infect Dis; 1991 Sep; 10(9):773-5. PubMed ID: 1810736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors.
    Bellei NC; Granato CF; Tomyiama H; Castelo A; Ferreira O
    Trans R Soc Trop Med Hyg; 1996; 90(2):122-5. PubMed ID: 8761567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of HTLV-I and HTLV-II infection in Puglia].
    Quarto M; Chironna M; Germinario C; Lopalco PL; Barbuti S
    Ann Ig; 1996; 8(6):649-55. PubMed ID: 9312232
    [No Abstract]   [Full Text] [Related]  

  • 7. Human T cell lymphotropic virus types I and II in intravenous drug users in San Francisco: risk factors associated with seropositivity.
    Feigal E; Murphy E; Vranizan K; Bacchetti P; Chaisson R; Drummond JE; Blattner W; McGrath M; Greenspan J; Moss A
    J Infect Dis; 1991 Jul; 164(1):36-42. PubMed ID: 2056217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low prevalence of human T-cell leukaemia virus-I and -II infection among drug users in Amsterdam, The Netherlands.
    van den Hoek JA; Al EJ; Huisman JG; Goudsmit J; Coutinho RA
    J Med Virol; 1991 Jun; 34(2):100-3. PubMed ID: 1890409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology and clinical aspects of human T-cell lymphotropic virus type I/II infection in a cohort of intravenous drug users in New York City.
    Brown LS; Chu A; Allain JP; Lee H; Cerney M; Nemoto T
    N Y State J Med; 1991 Mar; 91(3):93-7. PubMed ID: 2047026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases.
    Khabbaz RF; Onorato IM; Cannon RO; Hartley TM; Roberts B; Hosein B; Kaplan JE
    N Engl J Med; 1992 Feb; 326(6):375-80. PubMed ID: 1729620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem.
    Maayan S; Shufman EN; Engelhard D; Shouval D
    Addiction; 1994 Jul; 89(7):869-74. PubMed ID: 8081185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of markers for HTLV infection among australian injecting drug users.
    Crofts N; Silvester C; Ross M
    Med J Aust; 1992 Jul; 157(1):70-1. PubMed ID: 1353605
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of HTLV types I and II among drug users in King County, Washington.
    Thiede H; Harris NV; McGough JP; Roberts B; Khabbaz RF; Kaplan JE
    West J Med; 1994 Jun; 160(6):540-4. PubMed ID: 8053176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HTLV-I infection in selected populations in Australia and the western Pacific region.
    Nicholson SR; Efandis T; Dimitrakakis M; Karopoulos A; Lee H; Gust ID
    Med J Aust; 1992 Jun; 156(12):878-80. PubMed ID: 1463486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study of risk factors for seropositivity to human T-lymphotropic virus type I (HTLV-I) in Jamaica.
    Murphy EL; Wilks R; Hanchard B; Cranston B; Figueroa JP; Gibbs WN; Murphy J; Blattner WA
    Int J Epidemiol; 1996 Oct; 25(5):1083-9. PubMed ID: 8921498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seropositivity for HTLV-1 among Italian prisoners.
    Marinucci G; Di Giacomo C; Dato A; Ceralli F; Taborchi M; Galli C; Canavaggio M; Lee H
    AIDS; 1990 Sep; 4(9):930-2. PubMed ID: 2252573
    [No Abstract]   [Full Text] [Related]  

  • 17. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
    de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
    J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for HTLV-I and II in individuals attending a clinic for sexually transmitted diseases.
    Giuliani M; Rezza G; Lepri AC; Di Carlo A; Maini A; Crescimbeni E; Palamara G; Prignano G; Caprilli F
    Sex Transm Dis; 2000 Feb; 27(2):87-92. PubMed ID: 10676975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-I and -II in intravenous drug users from Sweden and Denmark.
    Blomberg J; Moestrup T; Frimand J; Hansson BG; Krogsgaard K; Grillner L; Nordenfelt E
    Scand J Infect Dis; 1994; 26(1):23-6. PubMed ID: 8191236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of HTLV-I and HTLV-II.
    Zanetti AR; Galli C
    N Engl J Med; 1992 Jun; 326(26):1783; author reply 1783-4. PubMed ID: 1350659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.